tag:blogger.com,1999:blog-2222630007427380394.post8216273746542169196..comments2023-12-20T04:18:41.617-06:00Comments on The Hunting of the Snark: A Different Type Of Piggish ScandalSusan of Texashttp://www.blogger.com/profile/00076915322771385454noreply@blogger.comBlogger6125tag:blogger.com,1999:blog-2222630007427380394.post-86484464337755049982015-09-22T08:59:22.650-05:002015-09-22T08:59:22.650-05:00Shorter Derek Lowe: Shkreli will ruin the grift fo...Shorter Derek Lowe: Shkreli will ruin the grift for everyone else.<br />http://blogs.sciencemag.org/pipeline/archives/2015/09/21/what-to-do-about-turing-and-the-others<br /><br /><br />"You have the ethical/humanitarian [arguments] obviously, but I can make a case without even appealing to those arguments – which is good, I’d say, because those sorts of arguments (as correct as they can be at times) rarely seem to make a lot of headway."<br /><br />That's because they are fought tooth-and-nail by people like Lowe and McArdle.<br /><br />"First off, they are horrendous for the reputation of the entire drug industry."<br /><br />Yes, we wouldn't want Pharma to get a reputation for greed.<br /><br />"Second, the awful publicity about these pricing strategies runs a serious risk of bringing the entire pricing structure of the industry under much heavier scrutiny and regulation."<br /><br />Right. The problem with not enough regulation is that it might not be allowed to continue.<br />Susan of Texashttps://www.blogger.com/profile/00076915322771385454noreply@blogger.comtag:blogger.com,1999:blog-2222630007427380394.post-29825631437453981382015-09-22T08:03:47.840-05:002015-09-22T08:03:47.840-05:00McArdle will probably echo Lowe and tisk-tisk Shkr...McArdle will probably echo Lowe and tisk-tisk Shkreli's actions while defending drug companies in general. <br /><br />Meanwhile my insurance company was soaked for artificially inflated colchicine and doxycycline. If insurance companies raise rates I bet McArdle will blame Obamacare.<br /><br />I would say nationalize it all but the banks ripped us off for billions and the taxpayer paid for it so why should either party do something about this, once a couple of people are fined? Susan of Texashttps://www.blogger.com/profile/00076915322771385454noreply@blogger.comtag:blogger.com,1999:blog-2222630007427380394.post-13110576801808136332015-09-22T07:27:15.383-05:002015-09-22T07:27:15.383-05:00I forgot to mention this with the link above, but ...I forgot to mention this with the link above, but the person writing that article is Derek Lowe. He's the original person Megan cited years ago in her original pieces about who pays for Pharma. <br />http://www.theatlantic.com/business/archive/2010/09/who-does-pharma-research/63505/Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-2222630007427380394.post-67580733504019421522015-09-22T07:16:24.918-05:002015-09-22T07:16:24.918-05:00http://blogs.sciencemag.org/pipeline/archives/2015...http://blogs.sciencemag.org/pipeline/archives/2015/09/21/martin-shkreli-has-one-idea-and-its-a-bad-oneAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-2222630007427380394.post-88141521446481136802015-09-22T05:44:37.433-05:002015-09-22T05:44:37.433-05:00I came across an informative thread at Boing Boing...I came across an informative thread at Boing Boing, and my first thought was "How will McMegan make hay of this?", with "How will Susan respond?"<br /><br />It sounds like a narrow little loophole that Shkreli and others have discovered. Or rather, a bottleneck, allowing them to extract rent from those who needs pass through it. The drugs are out of patent; anyone can synthesise a generic equivalent. But to put that generic drug on the US market, the competitor must obtain a supply of the old drug (so as to test them in parallel and establish bio-equivalence). And Shkreli's companies control distribution so they <i>won't sell it</i> to potential competitors.<br /><br />So all easily fixed. Apparently a Ms Clinton is proposing legislative changes to put an end to Shkreli's squalid little Kosovar-gangster-worthy racket. My *third* thought was "How will Republican presidential candidates come to the defence of Shkreli and his business model; how will they compete to out-praise his wealth-creating nobility?"Smut Clydehttps://www.blogger.com/profile/09409476490132867809noreply@blogger.comtag:blogger.com,1999:blog-2222630007427380394.post-22438902046894977082015-09-22T03:48:02.600-05:002015-09-22T03:48:02.600-05:00I figured you'd catch this story. When I saw ...I figured you'd catch this story. When I saw the clip of Shkreli proudly bullshitting on Bloomberg TV, I thought of McArdle, her free marketeer drug research BS, and how excited Shkreli must make her. (Perhaps she'll trot out another inane 'bold contrarian' piece defending him.)Batocchiohttps://www.blogger.com/profile/02193752396025012825noreply@blogger.com